GCL
PRVL

Glazer Capital LLC’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Glazer Capital LLC’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-145,915
Closed -$3.37M – 863
2020
Q4 		$3.37M Buy
+145,915
New +$3.37M 0.12% 180